search
Back to results

Lysine-specific Demethylase 1 and Salt-sensitivity in Humans

Primary Purpose

Healthy Subjects

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Aldosterone response to AngII LS
Renal blood flow response to salt
Vascular Stiffness
Sponsored by
Brigham and Women's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Healthy Subjects

Eligibility Criteria

25 Years - 45 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age 25-45 years
  • Caucasian or African American
  • No gender preference (anticipate 50% female)
  • Normotensive (screening blood pressure <140/90 mmHg)
  • No history of hypertension, diabetes, stroke, coronary artery disease, kidney disease, cancer, thyroid disease, preeclampsia, or hospitalizations in 6 months
  • Normal screening laboratory values (CMP, TSH, A1c)
  • Normal ECG
  • BMI <25 kg/m2

Exclusion Criteria:

  • Pregnancy
  • Breast feeding
  • Any medication or herbal preparation
  • >6oz alcohol/week
  • Tobacco use
  • Illicit drug use
  • Chronic NSAID use
  • Recent steroid use (injected, inhaled, oral)
  • Decongestant use in the past 2 weeks
  • Known sensitivity to infused Angiotensin II or para-amino hippurate

Sites / Locations

  • Brigham and Women's Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Placebo Comparator

Placebo Comparator

Placebo Comparator

Arm Label

Afr-Amer risk allele

Cauc risk allele

Afr-Amer non-risk allele

Cauc non-risk allele

Arm Description

African Americans carrying the LSD1 affected allele

Caucasians carrying the LSD1 affected allele

African Americans carrying the LSD1 non-risk allele

Caucasians carrying the LSD1 non-risk allele

Outcomes

Primary Outcome Measures

Aldosterone response to angiotensin II
Change in aldosterone, baseline to after angiotensin II by genotype/race

Secondary Outcome Measures

Renal blood flow response to dietary salt
Change in renal blood flow, high salt diet to low salt diet by genotype/race
Vascular stiffness response to angiotensin II
Change in vascular stiffness, baseline to after angiotensin II by genotype/race

Full Information

First Posted
January 20, 2017
Last Updated
February 7, 2023
Sponsor
Brigham and Women's Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03029806
Brief Title
Lysine-specific Demethylase 1 and Salt-sensitivity in Humans
Official Title
Lysine-specific Demethylase 1 and Salt-sensitivity in Humans
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
January 2, 2017 (Actual)
Primary Completion Date
January 2, 2022 (Actual)
Study Completion Date
January 2, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Brigham and Women's Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to investigate the role dietary salt plays in epigenetic regulation of blood pressure, focusing on the salt-sensitive regulatory enzyme Lysine-specific demethylase 1.
Detailed Description
The purpose of this study is to investigate the role dietary salt plays in epigenetic regulation of blood pressure in African American and Caucasians, focusing on the salt-sensitive regulatory enzyme Lysine-specific demethylase 1. This might help us understand why some people develop high blood pressure. Healthy volunteers will be screened for eligibility and invited to participate in a 2 weeks study. Week 1 will be consumption of a low salt diet. Week 2 will be a high salt diet. At the end of each week, participants will be admitted to a Clinical Research Center overnight and for one day. On the CRC, participants will remain fasting and supine overnight and then next morning undergo hormonal and vascular testing. This will consist of blood drawing, echocardiogram, vascular tonometry, and assessment of renal blood flow before and after a low-dose Angiotensin II infusion. The study outcome will compare how variants in the LSD1 gene affect hormonal and vascular responses according to race. This information will help us determine why some races and genetic profiles are more susceptible to detrimental effects of salt in the diet while others are protected against these effects.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy Subjects

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Heathy volunteers
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
88 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Afr-Amer risk allele
Arm Type
Active Comparator
Arm Description
African Americans carrying the LSD1 affected allele
Arm Title
Cauc risk allele
Arm Type
Placebo Comparator
Arm Description
Caucasians carrying the LSD1 affected allele
Arm Title
Afr-Amer non-risk allele
Arm Type
Placebo Comparator
Arm Description
African Americans carrying the LSD1 non-risk allele
Arm Title
Cauc non-risk allele
Arm Type
Placebo Comparator
Arm Description
Caucasians carrying the LSD1 non-risk allele
Intervention Type
Other
Intervention Name(s)
Aldosterone response to AngII LS
Intervention Description
Change in aldosterone from baseline to after Ang II infusion on a LS diet
Intervention Type
Other
Intervention Name(s)
Renal blood flow response to salt
Intervention Description
Change in renal blood flow: High salt to low salt diet
Intervention Type
Other
Intervention Name(s)
Vascular Stiffness
Intervention Description
Change in vascular stiffness, baseline compared to AngII
Primary Outcome Measure Information:
Title
Aldosterone response to angiotensin II
Description
Change in aldosterone, baseline to after angiotensin II by genotype/race
Time Frame
After 1 week dietary salt manipulation
Secondary Outcome Measure Information:
Title
Renal blood flow response to dietary salt
Description
Change in renal blood flow, high salt diet to low salt diet by genotype/race
Time Frame
After 1 week dietary salt manipulation on both diets
Title
Vascular stiffness response to angiotensin II
Description
Change in vascular stiffness, baseline to after angiotensin II by genotype/race
Time Frame
After 1 week dietary salt manipulation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age 25-45 years Caucasian or African American No gender preference (anticipate 50% female) Normotensive (screening blood pressure <140/90 mmHg) No history of hypertension, diabetes, stroke, coronary artery disease, kidney disease, cancer, thyroid disease, preeclampsia, or hospitalizations in 6 months Normal screening laboratory values (CMP, TSH, A1c) Normal ECG BMI <25 kg/m2 Exclusion Criteria: Pregnancy Breast feeding Any medication or herbal preparation >6oz alcohol/week Tobacco use Illicit drug use Chronic NSAID use Recent steroid use (injected, inhaled, oral) Decongestant use in the past 2 weeks Known sensitivity to infused Angiotensin II or para-amino hippurate
Facility Information:
Facility Name
Brigham and Women's Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
IPD will be shared first thru the publication of research results in peer-review scientific journals by the study investigator. IPD will be made available upon reasonable request from bona fide research organizations in an effort to provide broader impact and enrich public health knowledge. Research volunteer PHI will not be shared, and all participant data will be de-identified and coded. Only encrypted and secure network exchanges will be used for data transfer. Cost sharing my be required in order prepare datasets.
Citations:
PubMed Identifier
23054827
Citation
Krug AW, Tille E, Sun B, Pojoga L, Williams J, Chamarthi B, Lichtman AH, Hopkins PN, Adler GK, Williams GH. Lysine-specific demethylase-1 modifies the age effect on blood pressure sensitivity to dietary salt intake. Age (Dordr). 2013 Oct;35(5):1809-20. doi: 10.1007/s11357-012-9480-0. Epub 2012 Oct 2.
Results Reference
background
PubMed Identifier
22534796
Citation
Williams JS, Chamarthi B, Goodarzi MO, Pojoga LH, Sun B, Garza AE, Raby BA, Adler GK, Hopkins PN, Brown NJ, Jeunemaitre X, Ferri C, Fang R, Leonor T, Cui J, Guo X, Taylor KD, Ida Chen YD, Xiang A, Raffel LJ, Buchanan TA, Rotter JI, Williams GH, Shi Y. Lysine-specific demethylase 1: an epigenetic regulator of salt-sensitive hypertension. Am J Hypertens. 2012 Jul;25(7):812-7. doi: 10.1038/ajh.2012.43. Epub 2012 Apr 26.
Results Reference
background
PubMed Identifier
21873498
Citation
Pojoga LH, Williams JS, Yao TM, Kumar A, Raffetto JD, do Nascimento GR, Reslan OM, Adler GK, Williams GH, Shi Y, Khalil RA. Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension. Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H1862-71. doi: 10.1152/ajpheart.00513.2011. Epub 2011 Aug 26.
Results Reference
background

Learn more about this trial

Lysine-specific Demethylase 1 and Salt-sensitivity in Humans

We'll reach out to this number within 24 hrs